10 May 2018
Drug reviews and drug licensing
Showing results 41 - 50 of 100
Sorted by most recent
10 May 2018
6 April 2018
6 April 2018
5 March 2018
5 March 2018
12 February 2018
12 February 2018
5 February 2018
10 January 2018
Validation period: 12/30/2024, 11:53:23 AM - 12/31/2024, 11:53:23 AM
▼ Safinamide for Parkinson’s disease ▼ Bezlotoxumab for prevention of recurrence of Clostridium difficile infection ▼ Daclizumab withdrawn from the market worldwide Once-daily triple therapy inhaler for COPD ▼Dupilumab for atopic dermatitis Drugs and their names Kyleena – another levonorgestrel IUS Cladribine for multiple sclerosis Revised advice on switching between antiepileptic products ▼Patiromer for the management of hyperkalaemia